Impurity reference standards
Lenalidomide impurities & reference standards
Characterised Lenalidomide impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
70reference materials
1nitrosamine impurities
2isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Lenalidomide
191732-72-6 · C13H13N3O3
(S)-5-Amino-2-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic acid
- CAS
- 874760-71-1
- Formula
- C13H13N3O6
- MW
- 307.26 g/mol
VQ-026397
(S)-5-Amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid
- CAS
- 874760-72-2
- Formula
- C13H15N3O4
- MW
- 277.28 g/mol
VQ-022948
2-(4-Nitro-1-oxoisoindolin-2-yl)pentanedioic Acid
- CAS
- 295357-72-1
- Formula
- C13H12N2O7
- MW
- 308.24 g/mol
VQ-031480
2-(Hydroxymethyl)-3-nitrobenzoic Acid Methyl Ester
- CAS
- 1628915-10-5
- Formula
- C9H9NO5
- MW
- 211.17 g/mol
VQ-031479
2-Amino-N-(2,6-dioxopiperidin-3-yl)-6-methylbenzamide
- CAS
- 1015474-80-2
- Formula
- C13H15N3O3
- MW
- 261.28 g/mol
VQ-044506
3-(4-(Methylamino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
- CAS
- 2197421-58-0
- Formula
- C14H15N3O3
- MW
- 273.29 g/mol
VQ-031477
3-Amino-N-(2,6-dioxopiperidin-3-yl)-2-methylbenzamide
- CAS
- 1479889-22-9
- Formula
- C13H15N3O3
- MW
- 261.28 g/mol
VQ-044074
4-Amino-a-(3-amino-3-oxopropyl)1,3-dihydro-1-oxo-2H-Isoindole-2-aceticacidmethylester
- CAS
- 878782-79-7
- Formula
- C14H15N3O6
- MW
- 321.28 g/mol
VQ-048824
5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid
- CAS
- 1198299-72-7
- Formula
- C13H13N3O6
- MW
- 307.26 g/mol
VQ-026398
Diethyl 2 4 amino 1 oxoisoindolin 2 yl pentanedioate
- CAS
- 1063995-41-4
- Formula
- C17H22N2O5
- MW
- 334.4 g/mol
VQ-035370
Dimethyl 2-(4-nitro-1-oxoisoindolin-2-yl)pentanedioate
- CAS
- 827026-43-7
- Formula
- C15H16N2O7
- MW
- 336.3 g/mol
VQ-048828
Lenalidomide N-(3-Aminopropanoyl) Hydrochloride
- CAS
- 1407490-89-4
- Formula
- C16H19ClN4O4
- MW
- 366.8 g/mol
VQ-026400
FAQs — Lenalidomide impurities
Which Lenalidomide impurities do you supply?
We list 70 Lenalidomide-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Lenalidomide impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Lenalidomide impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Lenalidomide impurity standards
We reply within one business day with price, pack options, lead time and documentation.